Article: New England Journal of Medicine Study Reports that Testosterone Skin Patch Improves Sexual Functioning in Surgically Menopausal Women.

BOSTON, Sept. 6 /PRNewswire/ --

A multi-institutional research group has found that use of an experimental testosterone skin patch can relieve impaired sexual functioning in surgically menopausal women -- that is, women who have had their ovaries removed before natural menopause. The report in the Sept. 7 New England Journal of Medicine comes from a team led by researchers from the Massachusetts General Hospital (MGH) and Watson Laboratories, Inc.-Utah, a division of Watson Pharmaceuticals (NYSE: WPI), the developers of the patch.

The study was supported by Procter and Gamble Pharmaceuticals (NYSE: PG), which has licensed the marketing rights for the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!